6-79537371-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001122769.3(LCA5):c.-398G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00777 in 152,814 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0078 ( 10 hom., cov: 32)
Exomes 𝑓: 0.015 ( 0 hom. )
Consequence
LCA5
NM_001122769.3 5_prime_UTR
NM_001122769.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0320
Genes affected
LCA5 (HGNC:31923): (lebercilin LCA5) This gene encodes a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Alternatively spliced transcript variants are described. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 6-79537371-C-G is Benign according to our data. Variant chr6-79537371-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 358116.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00775 (1181/152336) while in subpopulation NFE AF= 0.0113 (767/68028). AF 95% confidence interval is 0.0106. There are 10 homozygotes in gnomad4. There are 603 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCA5 | NM_001122769.3 | c.-398G>C | 5_prime_UTR_variant | 1/8 | ENST00000369846.9 | NP_001116241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCA5 | ENST00000369846.9 | c.-398G>C | 5_prime_UTR_variant | 1/8 | 1 | NM_001122769.3 | ENSP00000358861.4 | |||
LCA5 | ENST00000392959.5 | c.-553G>C | 5_prime_UTR_variant | 1/9 | 1 | ENSP00000376686.1 | ||||
LCA5 | ENST00000467898.3 | c.-320G>C | 5_prime_UTR_variant | 1/7 | 5 | ENSP00000474463.1 | ||||
ENSG00000287811 | ENST00000692474.2 | n.187C>G | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.00776 AC: 1181AN: 152218Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
1181
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0146 AC: 7AN: 478Hom.: 0 Cov.: 0 AF XY: 0.0162 AC XY: 6AN XY: 370
GnomAD4 exome
AF:
AC:
7
AN:
478
Hom.:
Cov.:
0
AF XY:
AC XY:
6
AN XY:
370
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00775 AC: 1181AN: 152336Hom.: 10 Cov.: 32 AF XY: 0.00810 AC XY: 603AN XY: 74484
GnomAD4 genome
AF:
AC:
1181
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
603
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Leber congenital amaurosis 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | LCA5: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at